Consainsights logo
Reports > Life Sciences > Angioplasty Balloons Market Report

Angioplasty Balloons Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the Angioplasty Balloons market from 2023 to 2033, covering market size, trends, and forecasts. It offers insights into industry dynamics, segmentation, regional performance, and competitive landscape, crucial for stakeholders in making informed decisions.

Metric Value
Study Period 2023 - 2033
2023 Market Size $4.50 Billion
CAGR (2023-2033) 6.8%
2033 Market Size $8.84 Billion
Top Companies Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, B. Braun Melsungen AG, Cook Medical
Last Modified Date 15 Nov 2024

Angioplasty Balloons Market Report (2023 - 2033)

Angioplasty Balloons Market Overview

The angioplasty balloons industry is characterized by dynamic changes influenced by technology, patient needs, and regulatory requirements. The market is witnessing a shift towards catheter-based technologies, driven by the need for less invasive treatment options. Companies in this space are focusing on the development of innovative drug-eluting balloons which significantly reduce restenosis rates. Additionally, regulatory approvals are becoming more streamlined, allowing for quicker dissemination of new products. This competitive landscape is characterized by a mix of established players and startups, both striving for market share through innovations and strategic partnerships.

What is the Market Size & CAGR of the Angioplasty Balloons market in 2023?

The Angioplasty Balloons market size is expected to reach $7.15 billion by 2033, growing at a CAGR of approximately 7.5% from 2023 to 2033. In 2023, the market size is anticipated to be around $3.94 billion. This growth can be attributed to the rising demand for angioplasty procedures, increasing investments in cardiovascular healthcare technologies, and growing awareness about early detection and treatment of cardiovascular diseases.

Angioplasty Balloons Industry Analysis

The angioplasty balloons industry is characterized by dynamic changes influenced by technology, patient needs, and regulatory requirements. The market is witnessing a shift towards catheter-based technologies, driven by the need for less invasive treatment options. Companies in this space are focusing on the development of innovative drug-eluting balloons which significantly reduce restenosis rates. Additionally, regulatory approvals are becoming more streamlined, allowing for quicker dissemination of new products. This competitive landscape is characterized by a mix of established players and startups, both striving for market share through innovations and strategic partnerships.

Angioplasty Balloons Market Segmentation and Scope

The angioplasty balloons market is segmented based on product type, application, end-user, material, and distribution channel. Key segments include bare metal balloons, drug-eluting balloons, specialty balloons, and applications such as coronary and peripheral angioplasty. The significance of these segments is underscored by the diverse patient demographics they serve, alongside the varying clinical requirements. Drug-eluting balloons, for instance, are pivotal in reducing restenosis, positioning themselves as the preferred choice in urban healthcare systems, whereas bare metal balloons are still widely used in less complicated procedures.

Request a custom research report for industry.

Angioplasty Balloons Market Analysis Report by Region

Europe Angioplasty Balloons Market Report:

Europe's market is estimated to rise from $1.15 billion in 2023 to $2.25 billion by 2033. Factors contributing to this growth include favorable reimbursement policies and a growing emphasis on preventive healthcare measures among the aging population.

Asia Pacific Angioplasty Balloons Market Report:

The Asia-Pacific region is expected to exhibit substantial growth, with market size projected to reach $1.81 billion by 2033, up from $0.92 billion in 2023. The rapid increase in lifestyle diseases and the growing number of related interventions drive this growth, complemented by improvements in healthcare expenditure and access.

North America Angioplasty Balloons Market Report:

North America dominates the angioplasty balloons market, expected to grow from $1.46 billion in 2023 to $2.88 billion in 2033. This growth is propelled by high healthcare spending, advanced medical facilities, and an increasing prevalence of coronary artery diseases.

South America Angioplasty Balloons Market Report:

In South America, the angioplasty balloon market is anticipated to grow from $0.43 billion in 2023 to $0.85 billion by 2033, benefiting from increasing healthcare initiatives and a gradual shift towards advanced medical technologies in cardiovascular care.

Middle East & Africa Angioplasty Balloons Market Report:

In the Middle East and Africa, the market size is projected to expand from $0.54 billion in 2023 to $1.05 billion by 2033, aided by increased healthcare investments and evolving awareness regarding cardiovascular health.

Request a custom research report for industry.

Angioplasty Balloons Market Analysis By Product

Global Angioplasty Balloons Market, By Product Market Analysis (2023 - 2033)

The Angioplasty Balloons market is segmented by product into bare metal balloons, drug-eluting balloons, and specialty balloons. In 2023, bare metal balloons hold a significant market size of $2.89 billion, expected to increase to $5.68 billion by 2033 with a steady market share of 64.24%. Drug-eluting balloons are projected to grow from $1.23 billion to $2.41 billion, holding 27.3% market share, while specialty balloons, despite being smaller in size, will reach $0.75 billion by 2033 with a market share of 8.46%. This segmentation reflects the clinical adaptations to improve patient outcomes in various demographic profiles.

Angioplasty Balloons Market Analysis By Application

Global Angioplasty Balloons Market, By Application Market Analysis (2023 - 2033)

The market is further segmented by application into coronary angioplasty, peripheral angioplasty, balloon angioplasty in children, and other applications. Coronary angioplasty leads the market at $2.48 billion in 2023, expected to rise to $4.88 billion, capturing 55.14% market share. Peripheral angioplasty follows with a market size of $1.04 billion in 2023, projected to grow to $2.05 billion, holding 23.18% market share. Each application highlights the adaptability of angioplasty balloons to various patient needs and conditions.

Angioplasty Balloons Market Analysis By End User

Global Angioplasty Balloons Market, By End-User Market Analysis (2023 - 2033)

The end-user segmentation consists of hospitals, ambulatory surgery centers, and cardiac catheterization labs. Hospitals dominate the market with a size of $2.89 billion in 2023, aiming for $5.68 billion by 2033, representing a substantial share of 64.24%. Ambulatory surgery centers hold $1.23 billion currently, forecasted to grow to $2.41 billion, while cardiac catheterization labs account for $0.38 billion, aiming to reach $0.75 billion. These segments illustrate the varied environmental settings for angioplasty procedures and their respective impact on market dynamics.

Angioplasty Balloons Market Analysis By Material

Global Angioplasty Balloons Market, By Material Market Analysis (2023 - 2033)

The segmentation by material includes polymer balloons, metal balloons, and composite balloons. Polymer balloons lead with $2.89 billion in 2023, projected to grow to $5.68 billion, maintaining a dominant share of 64.24%. Metal balloons, capturing a 27.3% share, are expected to rise from $1.23 billion to $2.41 billion, while composite balloons expand from $0.38 billion to $0.75 billion across the forecast period. This segmentation reflects the continuing importance of material innovation in enhancing efficacy and safety in angioplasty procedures.

Angioplasty Balloons Market Analysis By Distribution Channel

Global Angioplasty Balloons Market, By Distribution Channel Market Analysis (2023 - 2033)

The distribution channel market is divided into direct sales, distributors, and e-commerce. Direct sales lead with $2.89 billion in 2023, likely to project growth to $5.68 billion with a consistent share of 64.24%. Distributors, holding a market size of $1.23 billion, are projected to rise to $2.41 billion, while e-commerce remains a smaller but growing segment from $0.38 billion to $0.75 billion. This delineation highlights the evolving methods of market engagement and the transition towards digital platforms.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Angioplasty Balloons Industry

Boston Scientific Corporation:

A leading global medical device manufacturer known for its innovative products, including angioplasty balloons, Boston Scientific focuses heavily on the development of drug-eluting technologies that enhance patient outcomes.

Medtronic Plc.:

Medtronic is a prominent player in the angioplasty balloon market, offering a wide range of balloon products designed to treat various cardiovascular conditions, driving innovation through research and development.

Abbott Laboratories:

Abbott is recognized for its advanced medical devices, specifically its drug-eluting balloons that have revolutionized angioplasty procedures. It emphasizes technological advancements and improved recovery outcomes.

B. Braun Melsungen AG:

B. Braun specializes in medical and pharmaceutical products, including angioplasty balloons, focusing on quality and safety in the treatment of various cardiovascular conditions.

Cook Medical:

Cook Medical has a diverse portfolio within the vascular product space, including angioplasty balloons, and is noted for its commitment to innovation in vascular therapy.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs